OmniAb, Inc. (OABI)
(Delayed Data from NSDQ)
$4.07 USD
-0.09 (-2.16%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $4.08 +0.01 (0.25%) 6:46 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
OmniAb, Inc. (OABI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$10.00 | $12.00 | $8.00 | 140.38% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for OmniAb, Inc. comes to $10.00. The forecasts range from a low of $8.00 to a high of $12.00. The average price target represents an increase of 140.38% from the last closing price of $4.16.
Analyst Price Targets (8 )
Broker Rating
OmniAb, Inc. currently has an average brokerage recommendation (ABR) of 1.13 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.13 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, seven are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 87.5% and 12.5% of all recommendations. A month ago, Strong Buy made up 87.5%, while Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/23/2024 | Cowen & Co. | Brendan Smith | Not Available | Strong Buy |
8/19/2024 | The Benchmark Company | Robert Wasserman | Strong Buy | Strong Buy |
8/12/2024 | H.C. Wainwright & Co. | Joseph Pantginis | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/9/2024 | Truist Securities | Srikripa Devarakonda | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
2/16/2024 | Craig-Hallum | Matthew G Hewitt | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.13 |
ABR (Last week) | 1.13 |
# of Recs in ABR | 8 |
Average Target Price | $10.00 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | -0.14 |
OABI FAQs
OmniAb, Inc. (OABI) currently has an average brokerage recommendation (ABR) of 1.13 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for OmniAb, Inc. (OABI) is $10.00. The current on short-term price targets is based on 4 reports.
The forecasts for OmniAb, Inc. (OABI) range from a low of $8 to a high of $12. The average price target represents a increase of $140.38 from the last closing price of $4.16.
The current UPSIDE for OmniAb, Inc. (OABI) is 140.38%
Based on short-term price targets offered by eight analysts, the average price target for OmniAb, Inc. comes to $10.00. The forecasts range from a low of $8.00 to a high of $12.00. The average price target represents an increase of 140.38% from the last closing price of $4.16.